Skip to main content

Healthcare Solutions

Study explores less invasive way to monitor colorectal cancer

Feb. 18, 2016—Investigators at Vanderbilt University Medical Center have published research regarding an important feature of colorectal cancer (CRC) that could eventually lead to the development of non-invasive means of monitoring cancer progression. After lung cancer, CRC is the second-most lethal cancer in the United States.

Read more


Liver transplant program celebrates 25 years of care

Feb. 18, 2016—Twenty-five years ago, Julie Damon’s family was preparing to say their goodbyes. Comatose and on life support at Vanderbilt University Medical Center (VUMC) with liver failure, the options for the 45-year-old wife and mother of two were slipping away.

Read more


Study leads to new heart transplant decision support tool

Feb. 18, 2016—Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant.

Read more


VU Inside: Dr. William Fissell’s Artificial Kidney

Feb. 12, 2016—Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William Fissell IV is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an artificial implantable kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart.

Read more


Cardiologist Hood keeps patients’ best interests at heart

Feb. 11, 2016—When Rob Hood, M.D., began practicing cardiology 30 years ago he could not have imagined that fitness would one day be measured on a device worn around his wrist.

Read more


Transplant Center initiative seeks to boost cancer education

Feb. 11, 2016—Lindsay Ramsey Smith, MSN, R.N., a quality consultant for the Vanderbilt Transplant Center (VTC), recently uncovered some interesting data that sparked a center-wide improvement project.

Read more


Slight chemical change may improve TB treatments: study

Feb. 11, 2016—One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.

Read more


Study identifies potential colon cancer biomarker

Feb. 11, 2016—A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.

Read more


Prostate cancer survivors’ risk of heart disease studied

Feb. 4, 2016—The 3 million prostate cancer survivors in the United States are likely to die from something other than cancer, thanks to early detection, effective treatment and the disease’s slow progression.

Read more


VICC joins other major cancer centers in HPV vaccine campaign

Feb. 4, 2016—In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in recommending increased HPV vaccination for the prevention of cancer.

Read more


Grant spurs research into trauma-induced vision loss

Feb. 4, 2016—Tonia Rex, Ph.D., and colleagues at the Vanderbilt Eye Institute are working to uncover how best to treat ocular trauma, the fourth leading cause of blindness worldwide.

Read more


Findings offer new insight on how cell division proteins work

Jan. 28, 2016—A family of proteins with critical roles in cell division, synaptic transmission and cell migration don’t all function the way scientists thought they did, according to two new studies led by Vanderbilt researchers.

Read more


Page 8 of 19« First...56789101112...Last »